Inactive Instrument

News Cell Impact AB Swiss Exchange

Equities

CI.B

SE0005003217

End-of-day quote Swiss Exchange Other stock markets
- ^SEK	-

05-14	Cell Impact AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-07	Cell Impact AB Signs Main Agreement with F.C.C	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cell Impact Q1 2024: Laying the groundwork for large-volume deliveries	05-14	AQ
Cell Impact AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Cell Impact AB Signs Main Agreement with F.C.C	05-07	CI
Cell Impact Signs Main Agreement with F.C.C.	05-06	AQ
Extended Collaboration between Cell Impact and F.C.C.	05-06	AQ
Cell Impact signs agreement valued at 3.2 million SEK	04-26	AQ
Cell Impact AB Signs Agreement Valued At SEK 3.2 Million	04-26	CI
Communiqué from the Annual General Meeting 2024 of Cell Impact AB (publ)	04-25	AQ
Cell Impact AB Announces Board and Committee Changes	04-25	CI
Notice of the annual general meeting of Cell Impact (publ)	03-22	AQ
Cell Impact publishes annual report for 2023	03-22	AQ
Cell Impact Meets Representatives of the Hydrogen Industry in the United States	03-15	AQ
Cell Impact has received an order worth SEK 18 million in the field of electrolysis	03-08	AQ
Cell Impact Receives an Order Worth SEK 18 Million in the Field of Electrolysis	03-08	CI
Cell Impact Q4 2023: Expected weak quarter but financing secured	02-16	AQ
Cell Impact AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-16	CI
Cell Impact AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW